Interest-bearing debt
Pass11%of market cap
0%limit 30%
UK annual report (ESEF), FY ending 2025-12-31
AZN.L
London prices aren’t shown yet.
Verdict
Passes the business-activity screen and all three AAOIFI financial tests, each from AstraZeneca plc's own filings.
AAOIFI Shari'ah Standard No. 21 · screened 15 Oct 2026
Each bar shows the figure against its limit; the line marks the limit.
11%of market cap
UK annual report (ESEF), FY ending 2025-12-31
2.2%of market cap
UK annual report (ESEF), FY ending 2025-12-31
≤ 0.6%of revenue
Upper bound: total finance income in the filed statements, which includes interest income. No separate interest-income figure is filed.
No prohibited activity (alcohol, gambling, tobacco, conventional finance, pork, adult content) found in the sector, SEC industry or company name.
See the business + financial screening, dividend purification ratio, and category-by-category compliance status.
Upgrade to Pro